NasdaqGM - Nasdaq Real Time Price USD
Prime Medicine, Inc. (PRME)
1.4600
0.0000
(0.00%)
At close: June 13 at 4:00:00 PM EDT
1.5200
+0.06
+(4.11%)
After hours: June 13 at 7:56:13 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 30.89M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
LIU DAVID R Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.60 per share. | Direct | 33,590 | Jun 11, 2025 |
REINE ALLAN Chief Executive Officer | Purchase at price 1.18 per share. | Direct | 147,150 | May 21, 2025 |
LEE ANN LOUISE Officer | Purchase at price 1.13 per share. | Direct | 113,000 | May 21, 2025 |
BRUDNICK RICHARD Officer | Purchase at price 1.19 per share. | Direct | 23,790 | May 20, 2025 |
GOTTESDIENER KEITH MICHAEL Chief Executive Officer | Stock Gift at price 0.00 per share. | Indirect | 0 | Oct 8, 2024 |
GOTTESDIENER KEITH MICHAEL Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Jun 5, 2024 |
NELSEN ROBERT TAYLOR Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.25 per share. | Indirect | 20,000,000 | Feb 15, 2024 |
ARCH VENTURE PARTNERS X LLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.25 per share. | Indirect | 20,000,000 | Feb 15, 2024 |
GOTTESDIENER KEITH MICHAEL Officer and Director | Stock Gift at price 0.00 per share. | Indirect | 0 | Nov 10, 2023 |
LIU DAVID R Beneficial Owner of more than 10% of a Class of Security | Stock Gift at price 0.00 per share. | Direct | 0 | Jul 21, 2023 |
LIU DAVID R Beneficial Owner of more than 10% of a Class of Security | Stock Gift at price 0.00 per share. | Direct | 0 | Jul 21, 2023 |
GV 2019 GP, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 14.97 - 15.06 per share. | Indirect | 847,744 | Jun 21, 2023 |
GV 2019 GP, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 14.92 - 15.02 per share. | Indirect | 1,092,435 | Jun 16, 2023 |
Related Tickers
BEAM Beam Therapeutics Inc.
17.06
-2.18%
NTLA Intellia Therapeutics, Inc.
8.31
-0.48%
VERV Verve Therapeutics, Inc.
6.16
-2.53%
CRBU Caribou Biosciences, Inc.
1.1100
-4.31%
EDIT Editas Medicine, Inc.
1.9700
-9.63%
SANA Sana Biotechnology, Inc.
2.5900
+1.97%
ABSI Absci Corporation
2.7800
-2.11%
FATE Fate Therapeutics, Inc.
1.2750
-8.93%
MGX Metagenomi, Inc.
1.4300
-1.38%
SGMO Sangamo Therapeutics, Inc.
0.4910
-2.39%